tiprankstipranks
MaxCyte Inc (GB:MXCT)
LSE:MXCT

MaxCyte (MXCT) Financial Statements

9 Followers

MaxCyte Financial Overview

MaxCyte's market cap is currently ―. The company's EPS TTM is p-0.28; its P/E ratio is -11.32; MaxCyte is scheduled to report earnings on August 7, 2024, and the estimated EPS forecast is p-0.10. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 11.34M$ 15.66M$ 8.00M$ 9.04M$ 8.58M
Gross Profit$ 9.94M$ 14.09M$ 7.21M$ 7.67M$ 7.58M
EBIT$ -12.28M$ -8.10M$ -11.25M$ -10.51M$ -10.88M
EBITDA$ -11.16M$ -6.99M$ -11.65M$ -11.40M$ -11.65M
Net Income Common Stockholders$ -9.53M$ -5.28M$ -11.25M$ -10.51M$ -10.88M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 157.51M$ 168.29M$ 190.24M$ 216.11M$ 224.65M
Total Assets$ 257.93M$ 268.27M$ 266.73M$ 271.20M$ 281.54M
Total Debt$ 18.64M$ 18.74M$ 16.08M$ 16.21M$ 16.25M
Net Debt$ -138.87M$ -149.54M$ -174.16M$ -199.90M$ -208.40M
Total Liabilities$ 31.57M$ 36.11M$ 33.35M$ 30.22M$ 33.73M
Stockholders Equity$ 226.36M$ 232.17M$ 233.38M$ 240.98M$ 247.82M
Cash Flow-
Free Cash Flow$ -11.37M$ 66.80K$ -8.96M$ -10.61M$ -5.87M
Operating Cash Flow$ -10.56M$ 981.70K$ -8.24M$ -10.10M$ -4.32M
Investing Cash Flow$ -14.40M$ -4.14M$ 2.81M$ 26.67M$ 29.64M
Financing Cash Flow$ 703.00K$ 493.00K$ 36.70K$ 156.70K$ 1.46M
Currency in USD

MaxCyte Earnings and Revenue History

MaxCyte Debt to Assets

MaxCyte Cash Flow

MaxCyte Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis